Jeffrey del Carmen is CCO at CATALYST PHARMACEUTICALS, INC. (CPRX). They have made 6 open-market trades across 1 company since 2022, most recently 2025-12-29.
CIK 0001816477
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CPRX | 14,337 | $451K |
Shares reported on the most recent Form 4, priced at the 2025-12-30 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CPRX | SELL | 2025-11-26 | 2025-11-28 | $23.33 | $512K | -1.5% | +4.0% | +7.5% |
| CPRX | SELL | 2025-03-03 | 2025-03-05 | $22.89 | $1.4M | +0.8% | +6.6% | +15.1% |
| CPRX | SELL | 2024-08-09 | 2024-08-13 | $18.43 | $776K | +3.8% | +3.6% | +19.8% |
| CPRX | SELL | 2024-06-07 | 2024-06-11 | $16.07 | $242K | -3.5% | +2.3% | +23.3% |
| CPRX | SELL | 2023-03-29 | 2023-03-30 | $16.70 | $1.3M | +6.1% | +2.4% | -19.3% |
| CPRX | SELL | 2022-11-11 | 2022-11-15 | $16.04 | $2.5M | +4.1% | +6.3% | -1.9% |
| CPRX | SELL · Routine | 2022-08-19 | 2022-08-22 | $14.05 | $199K | -3.3% | -13.8% | +7.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.